Improving Plaque Assays for Human Coronavirus NL63
Author Information
Author(s): Petra Herzog, Christian Drosten, Marcel A. Müller
Primary Institution: Bernhard Nocht Institute for Tropical Medicine
Hypothesis
Can human colon carcinoma cells (CaCo-2) be used to establish effective plaque assays for hCoV-NL63?
Conclusion
CaCo-2 cells support hCoV-NL63 replication better than LLC-MK2 cells, enabling effective plaque assays.
Supporting Evidence
- CaCo-2 cells replicated hCoV-NL63 more than 100 fold more efficiently than LLC-MK2 cells.
- Avicel overlay produced large and clear plaques from the 4th day of infection.
- Plaque assays with agarose overlay increased viral infectivity by 1 log 10 PFU/mL.
Takeaway
Scientists found that a specific type of human cell works much better for growing a cold virus, which helps in making better tests for medicines.
Methodology
The study tested 12 different cell cultures for their ability to replicate hCoV-NL63 and evaluated various overlay techniques for plaque assays.
Limitations
The study primarily focused on a limited number of cell lines and may not represent all possible cell types for hCoV-NL63.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website